Authors
John Michael O’Brien, PharmD, MPH, is president and CEO of the National Pharmaceutical Council.
ORCID ID: 0009-0003-1578-2500
Medical director, Asklepios Tumour Biology Centre
Cate Lockhart, PharmD, PhD, is the chief science officer of the Academy of Managed Care Pharmacy and the executive director of the Biologics and Biosimilars Collective Intelligence Consortium.
Jonathan Rothwell is the principal economist at Gallup and a non-resident senior fellow at the Brookings Institution. He is the author of “A Republic of Equals: A Manifesto for a Just Society,” and holds a PhD from Princeton University.
Advertisement
Advertisement
Trending on AJMC
1
FDA Clears First Alzheimer Blood Test for Adults as Young as 40
2
MFN Drug Agreements Could Raise Prices Worldwide
3
Dosing, Tolerability, and Formulary Impact: Aripiprazole and Quetiapine XR in MDD
4
Newer Agents, New Advantages: Brexpiprazole, Cariprazine, and Lumateperone in MDD
5


